Lack of Association of Vascular Risk Factors with HIV-Associated Neurocognitive Disorders in cART-Treated Adults Aged ≥ 50 Years in Tanzania
- PMID: 38932112
- PMCID: PMC11209468
- DOI: 10.3390/v16060819
Lack of Association of Vascular Risk Factors with HIV-Associated Neurocognitive Disorders in cART-Treated Adults Aged ≥ 50 Years in Tanzania
Abstract
HIV-associated neurocognitive disorders (HAND) are highly prevalent in those ageing with HIV. High-income country data suggest that vascular risk factors (VRFs) may be stronger predictors of HAND than HIV-disease severity, but data from sub-Saharan Africa are lacking. We evaluated relationships of VRFs, vascular end-organ damage and HAND in individuals aged ≥ 50 in Tanzania. c-ART-treated individuals were assessed for HAND using consensus criteria. The prevalence of VRFs and end organ damage markers were measured. The independent associations of VRFs, end organ damage and HAND were examined using multivariable logistic regression. Data were available for 153 individuals (median age 56, 67.3% female). HAND was highly prevalent (66.7%, 25.5% symptomatic) despite well-managed HIV (70.5% virally suppressed). Vascular risk factors included hypertension (34%), obesity (10.5%), hypercholesterolemia (33.3%), diabetes (5.3%) and current smoking (4.6%). End organ damage prevalence ranged from 1.3% (prior myocardial infarction) to 12.5% (left ventricular hypertrophy). Measured VRFs and end organ damage were not independently associated with HAND. The only significant association was lower diastolic BP (p 0.030, OR 0.969 (0.943-0.997). Our results suggest that vascular risk factors are not major drivers of HAND in this setting. Further studies should explore alternative aetiologies such as chronic inflammation.
Keywords: HIV; HIV-Associated Neurocognitive Disorders (HAND); cognitive impairment; older adults; sub-Saharan Africa; vascular risk factors.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.Int Psychogeriatr. 2023 Jul;35(7):339-350. doi: 10.1017/S1041610221000156. Epub 2021 Mar 24. Int Psychogeriatr. 2023. PMID: 33757616
-
HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.J Acquir Immune Defic Syndr. 2022 Jun 1;90(2):214-222. doi: 10.1097/QAI.0000000000002934. J Acquir Immune Defic Syndr. 2022. PMID: 35125473
-
Risk factors for symptomatic HIV-associated neurocognitive disorder in adults aged 50 and over attending a HIV clinic in Tanzania.Int J Geriatr Psychiatry. 2020 Oct;35(10):1198-1208. doi: 10.1002/gps.5357. Epub 2020 Jul 20. Int J Geriatr Psychiatry. 2020. PMID: 32497330
-
Recent advances in HIV-associated neurocognitive disorders: a focus on older adults and sub-Saharan Africa.Curr Opin Psychiatry. 2024 Mar 1;37(2):87-93. doi: 10.1097/YCO.0000000000000919. Epub 2023 Dec 21. Curr Opin Psychiatry. 2024. PMID: 38226543 Review.
-
HIV, Vascular Risk Factors, and Cognition in the Combination Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis.J Int Neuropsychol Soc. 2021 Apr;27(4):365-381. doi: 10.1017/S1355617720001022. Epub 2020 Nov 9. J Int Neuropsychol Soc. 2021. PMID: 33161930 Free PMC article. Review.
References
-
- UNAIDS Global HIV & AIDS Statistics–2020 Fact Sheet. [(accessed on 1 July 2021)]. Available online: https://www.unaids.org/en/resources/fact-sheet.
-
- Patel P., Rose C.E., Collins P.Y., Nuche-Berenguer B., Sahasrabuddhe V.V., Peprah E., Vorkoper S., Pastakia S.D., Rausch D., Levitt N.S. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: A systematic review and meta-analysis. AIDS Lond. Engl. 2018;32((Suppl. 1)):S5. doi: 10.1097/QAD.0000000000001888. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical